REFERENCES
- Speth PA, van Hoesel QG, Haanen C. Clinical pharmacoki-netics of doxorubicin. Clin Pharmacokinet 1988; 15: 15–31.
- Bean CI, Armstrong MJ, Galloway SM. Effect of sampling time on chromosomal aberration yield for 7 chemicals in Chinese hamster ovary cells. Mutat Res 1992; 265: 31–44.
- Barber DA, Harris SR. Oxygen free radicals and antioxidants: a review Am Pharm 1994; 34: 26–35.
- Au WW, Hsu TC. The genotoxic effects of adriamycin in somatic and germinal cells of the mouse. Mutat Res 1980; 79: 351–61.
- Wilson RL. Free radical-induced biological damage and the critical roles of vitamin A, vitamin C, vitamin D and vitamin E and of copper, iron, selenium and zinc. J Nutr Sci Vitaminol 1992; 21: 541–4.
- Antunes LM, Takahashi CS. Effects of high doses of vitamins C and E against doxorubicin-induced chromosomal damage in Wistar rat bone marrow cells. Mutat Res 1998; 419: 137–43.
- Sardar S, Chakrabarty A, Chatterjee M. Comparative effec-tiveness of vitamin D3 and vitamin E on peroxidation of lipids and enzymes of the hepatic antioxidant system in Sprague-Dawley rats. Int .1 Vit Nutr Res 1996; 66: 39–45.
- Preston RJ, Dean BJ, Galloway S, Holden H, McFee AF, Shelby M. Mammalian in vivo cytogenetic assays. Analysis of chromosome aberrations in bone marrow cells. Mutat Res 1987; 189: 157–65.
- Chatterjee M. Vitamin D and genomic stability. Mutat Res 2002; 475: 69–88.
- Ford CE, Hammerton JL. A colchicine, hypotonic-citrate, squash sequence for mammalian chromosomes. Stain Technol 1956; 31: 247–54.
- Savage JR. Classification and relationships of induced chro-mosomal structural changes. J Med Genet 1976; 13: 103–22.
- Rosselli F, Zaccaro L, Venturi M, Rossi AM. Persistence of drug-induced chromosome aberrations in peripheral blood lymphocytes of the rat. Mutat Res 1990; 232: 107–14.
- Dulout FN, Larramendy ML, Olivero OA. Effect of caffeine on the frequency of chromosome aberrations induced in vivo by triethylenemelamine (TEM) and adriamycin (ADR) in mice. Mutat Res 1981; 82: 295–304.
- Fridberg EC, Ehlmann UK, Williams JI. Human diseases associated with defective DNA repair. Adv Radiat Biol 1979; 8: 85–174.
- Basak R, Saha BK, Chatterjee M. Inhibition of diethylnitro-samine-induced rat liver chromosomal aberrations and DNA-strand breaks by synergistic supplementation of vanadium and 1a-25-dihydroxyvitamin D3. Biochim Biophys Acta 2000; 1502: 273–82.
- Sarkar A, Saha BK, Basak R, Mukhopadhyay I, Karmakar R, Chatterjee M. Anticlastogenic potential of 1a-25-dihydr-oxyvitamin D3 in murine lymphoma. Cancer Lett 2000; 150: 1–13.
- Wiseman H. Vitamin D is a membrane antioxidant. Ability to inhibit iron-dependent lipid peroxidation in liposomes com-pared to cholesterol, ergosterol and tamoxifen and relevance to anticancer action. FEBS Lett 1993; 326: 285–8.
- Meister A. Glutathione metabolism and its selective modifica-tion. J Biol Chem 1988; 263: 17206–8.
- Takayama H, Kittaka A, Fujishima T, Suhara Y. Design, synthesis, and biological studies of the A-ring-modified 1,25-dihydroxyvitamin D3 analogs. Recent Results Cancer Res 2003; 164: 289–317.
- Karmakar R, Banik S, Chatterjee M. Inhibitory effect of vitamin D3 on 3'-methy1-4-dimethyl-amino-azobenzene-induced rat hepatocarcinogenesis: a study on antioxidant defense enzymes. J Exp Ther Oncol 2002; 2: 193–9.
- Han SH, Jeon JH, Ju HR, et al. VDUP1 upregulated by TGF-betal and 1,25-dihydroxyvitamin D3 inhibits tumor cell growth by blocking cell-cycle progression. Oncogene 2003; 26: 4035–46.